Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(97 sites)
United States
Research Site, Phoenix, Arizona Research Site, Los Angeles, California Research Site, Washington D.C., District of Columbia Research Site, Chicago, Illinois Research Site, Chicago, Illinois Research Site, New Orleans, Louisiana Research Site, Bethesda, Maryland Research Site, Saint Paul, Minnesota Research Site, New Hyde Park, New York Research Site, New York, New York Research Site, The Bronx, New York Research Site, Valhalla, New York Research Site, Durham, North Carolina Research Site, Cincinnati, Ohio Research Site, Cleveland, Ohio Research Site, Columbus, Ohio Research Site, Portland, Oregon Research Site, Philadelphia, Pennsylvania Research Site, Greenville, South Carolina Research Site, El Paso, Texas Research Site, Houston, Texas Research Site, Salt Lake City, Utah Argentina
Research Site, Buenos Aires Research Site, San Miguel de Tucumán Brazil
Research Site, Porto Alegre Research Site, Ribeirão Preto Canada
Research Site, Calgary, British Columbia Research Site, Vancouver, British Columbia Research Site, Toronto, Ontario Colombia
Research Site, Barranquilla France
Research Site, Le Kremlin-Bicêtre Germany
Research Site, Freiburg im Breisgau Research Site, Sankt Augustin Japan
Research Site, Bunkyō City Research Site, Bunkyō City Research Site, Kawasaki-shi Research Site, Shinjuku-ku Mexico
Research Site, Atizapán de Zaragoza Research Site, Guadalajara Spain
Research Site, Esplugues de Llobregat Research Site, Santiago de Compostela United Kingdom
Research Site, Birmingham Research Site, Manchester Research Site, Southampton